Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (A Development Stage Company) (Parentheticals)

 v2.3.0.11
Balance Sheets (A Development Stage Company) (Parentheticals)
Jun. 30, 2011
Mar. 31, 2011
Preferred Stock, authorized 200,000,000 20,000,000
Common Stock, authorized 300,000,000 300,000,000
Common stock, issued 97,000,000 97,000,000